How GDPR compliant pseudonymization requirements have evolved from prior standards:
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
Is "pseudonymised" dtat treated as "Personal Data"?
* In 2007, prior to the proliferation of Big Data, the article “Pseudonymisation of Personal Data in Pharmaceutical Research: The Art of Disguising Identities” published in the Regulatory Affairs Journal Pharma described the then-current state-of-the- art (“2007 Article”)- Twelve years later, in 2019, data protection has evolved considerably, not only in the context of Pharmaceutical Research but generally across all data-consuming verticals. This chart provides a straig htfon/vard lens through which to view this evolution: specifically, how the meaning of “pseudonymisation,” key to the 2007 Article, has itselfeVOIVed in those intervening twelve years. (see httpsJMwwchoganlovells.coml~lmedialhogan-lovellslpdfi'publicationlsept07rajpharmanauwelaertshortonjdf).
